ABSTRACT

KEYWORDS

REFERENCES

1. Haydour Q, Hage CA, Carmona EM, Epelbaum O, Evans SE, Gabe LM, et al. Diagnosis of fungal infections. A systematic review and meta-analysis supporting American Thoracic Society Practice Guideline. Ann Am Thorac Soc. 2019;16(9):1179-1188. Available in: https://doi.org/10.1513/annalsats.201811-766oc

2. Madrid G. III Temas especiales: las micosis pulmonares. Rev Mex Tuberc. 1948;9(46):32-55.

3. Heung LJ, Wiesner DL, Wang K, Rivera A, Hohl TM. Immunity to fungi in the lung. Semin Immunol. 2023;66:101728. Available in: https://doi.org/10.1016/j.smim.2023.101728

4. Laniado-Laborín R, Arathoon EG, Canteros C, Muñiz-Salazar R, Rendon A. Coccidioidomycosis in Latin America. Med Mycol. 20191;57(Supplement 1):S46-S55. Available in: https://doi.org/10.1093/mmy/myy037

5. Mazi PB, Rauseo AM, Spec A. Blastomycosis. Infect Dis Clin North Am. 2021;35(2):515-530. Available in: https://doi.org/10.1016/j.idc.2021.03.013

6. Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA, et al. Treatment of community-acquired pneumonia in immunocompromised adults: a Consensus Statement Regarding Initial Strategies. Chest. 2020;158(5):1896-1911. Available in: https://doi.org/10.1016/j.chest.2020.05.598

7. Ding X, Sun G, Fei G, Zhou X, Zhou L, Wang R. Pulmonary actinomycosis diagnosed by transbronchoscopic lung biopsy: A case report and literature review. Exp Ther Med. 2018;16(3):2554-2558. Available in: https://doi.org/10.3892/etm.2018.6483

8. Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737-779. Available in: https://doi.org/10.1007/s15010-017-1042-z